Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging’s platform
Lumexa Imaging, one of the nation’s largest providers of outpatient imaging services, announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company’s enterprise growth strategy, with responsibility for expanding Lumexa Imaging’s platform through joint ventures, acquisitions, and de novo development.
In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capital. He will work closely with the CEO, CFO, Chief Strategy Officer, and operations leadership to ensure growth initiatives are tightly aligned with Lumexa Imaging’s clinical excellence, operational performance, and long-term financial objectives.
“Kyle brings a powerful combination of strategic insight, execution discipline, and commercial leadership,” said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. “At a time when outpatient imaging is benefiting from strong secular tailwinds—including site-of-care migration, growing demand for advanced diagnostics, and a highly fragmented provider landscape, his track record of scaling growth platforms and delivering measurable results will be instrumental as we drive same-center performance and accelerate disciplined geographic expansion.”
Read More: SalesTechStar Interview with Travis Rehl, CTO and Head of Product at Innovative Solutions
Lynch will also lead Lumexa Imaging’s Sales Center of Excellence, advancing a scalable, data-driven commercial model across the enterprise. His focus will include enhancing sales productivity, standardizing performance metrics, and driving consistent referral growth and same-center performance across Lumexa Imaging’s national footprint.
“Lumexa Imaging has built a differentiated platform grounded in clinical excellence, operational rigor, and a strong patient and provider experience,” said Lynch. “I look forward to partnering with the leadership team to scale that platform, expand access to high-quality care, and deliver long-term value for patients, partners, and shareholders.”
Prior to joining Lumexa Imaging, Lynch served as SVP of Strategy and Development at SCA Health, where he led enterprise growth initiatives across a national healthcare services platform. He brings deep experience in building high-performing business development organizations, executing complex transactions, and driving growth strategies that translate into durable financial performance.
Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and more than 185 outpatient imaging centers across 13 states, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.
Read More: Why Pipeline-Driven Sales Will Dominate and Become the New Era of Sales Efficiencies
